EPM
AMED

Equitec Proprietary Markets’s Amedisys AMED Stock Holding History

Equitec Proprietary Markets’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,000
Closed -$1.61M – 70
2025
Q1 		$1.57M Buy
17,000
+11,000
+183% +$1.01M 1.12% 16
2024
Q4 		$545K Sell
6,000
-4,500
-43% -$413K 0.53% 16
2024
Q3 		$1.01M Sell
10,500
-1,500
-13% -$146K 0.86% 15
2024
Q2 		$1.1M Sell
12,000
-3,600
-23% -$334K 1.4% 13
2024
Q1 		$1.44M Buy
15,600
+500
+3% +$46.9K 0.88% 17
2023
Q4 		$1.44M Buy
15,100
+800
+6% +$74.7K 1.06% 22
2023
Q3 		$1.34M Buy
+14,300
New +$1.32M 0.33% 31

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Equitec Proprietary Markets's AMED Position: Q2 2025 in Review

Equitec Proprietary Markets sold out of Amedisys (AMED) in Q2 2025, closing a stake of 17,000 shares — an estimated $1.61M sold.

Equitec Proprietary Markets first reported a position in AMED in Q3 2023 and held it in 7 quarters. The position peaked at $1.57M in Q1 2025. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Equitec Proprietary Markets reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Equitec Proprietary Markets sold 17,000 Amedisys shares in Q2 2025, an estimated $1.61M.
  • Equitec Proprietary Markets first reported a position in Amedisys in Q3 2023 and held it in 7 quarters.
  • Equitec Proprietary Markets's Amedisys position peaked at $1.57M in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Equitec Proprietary Markets's 13F filing for Q2 2025, filed 6 Aug 2025.